The activation and cross-talk of AMPKα and MEK/ERK1/2 signaling pathways, and reciprocal interplay of RUNX3 and FOXO3a expression contribute to the overall responses of baicalein, which unveils a novel molecular mechanism by which baicalein controls human lung cancer cell growth (Figure 6F). The gene discussed is MAP2K7; the disease is lung carcinoma.